相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis
Dalia Rotstein et al.
NATURE REVIEWS NEUROLOGY (2019)
Epidemiology and treatment of multiple sclerosis in elderly populations
Caila B. Vaughn et al.
NATURE REVIEWS NEUROLOGY (2019)
Clinical trials of disease-modifying agents in pediatric MS Opportunities, challenges, and recommendations from the IPMSSG
Emmanuelle Waubant et al.
NEUROLOGY (2019)
Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data
Francesca Bovis et al.
BMC MEDICINE (2019)
Age and the risks of high-efficacy disease modifying drugs in multiple sclerosis
Finja Schweitzer et al.
CURRENT OPINION IN NEUROLOGY (2019)
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
Giancarlo Comi et al.
LANCET NEUROLOGY (2019)
The Italian multiple sclerosis register
Maria Trojano et al.
NEUROLOGICAL SCIENCES (2019)
Pediatric multiple sclerosis: a review
Raed Alroughani et al.
BMC NEUROLOGY (2018)
Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeutics
Nicolas Collongues et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)
Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeutics
Nicolas Collongues et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2018)
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting
Maria Trojano et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions
Alessandra Musella et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
The Influence of Menopause in Multiple Sclerosis Course: A Longitudinal Cohort Study
Filipa Ladeira et al.
EUROPEAN NEUROLOGY (2018)
Treatment decisions in multiple sclerosis - insights from real-world observational studies
Maria Trojano et al.
NATURE REVIEWS NEUROLOGY (2017)
Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study
Francis Guillemin et al.
NEUROEPIDEMIOLOGY (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments
Ann Marie Weideman et al.
FRONTIERS IN NEUROLOGY (2017)
Prognostic Indicators in Pediatric Clinically Isolated Syndrome
Pietro Iaffaldano et al.
ANNALS OF NEUROLOGY (2017)
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort
Riley Bove et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort
Riley Bove et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Predictors of Long-Term Disability Accrual in Relapse-Onset Multiple Sclerosis
Vilija G. Jokubaitis et al.
ANNALS OF NEUROLOGY (2016)
Long-Term Evolution of Multiple Sclerosis Disability in the Treatment Era
Bruce A. C. Cree et al.
ANNALS OF NEUROLOGY (2016)
Observational data: Understanding the real MS world
Tomas Kalincik et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Pediatric multiple sclerosis Conventional first-line treatment and general management
Angelo Ghezzi et al.
NEUROLOGY (2016)
Observational data: Understanding the real MS world
Tomas Kalincik et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment
Afsaneh Shirani et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Predictors of disability worsening in clinically isolated syndrome
Vilija G. Jokubaitis et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Neuropsychological features in childhood and juvenile multiple sclerosis Five-year follow-up
Maria P. Amato et al.
NEUROLOGY (2014)
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis
Melih Tutuncu et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Early Relapses, Onset of Progression, and Late Outcome in Multiple Sclerosis
Antonio Scalfari et al.
JAMA NEUROLOGY (2013)
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study
Virginia Devonshire et al.
LANCET NEUROLOGY (2012)
Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis
T. Chitnis et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis
Aaron E. Miller et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Effect of gender on late-onset multiple sclerosis
Riley M. Bove et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cladribine tablets for relapsing-remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study
Kottil Rammohan et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2012)
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
Gavin Giovannoni et al.
LANCET NEUROLOGY (2011)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Impact of exposure to interferon beta-1a on outcomes in patients with relapsing–remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study
Bernard Uitdehaag et al.
Therapeutic Advances in Neurological Disorders (2011)
The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
Antonio Scalfari et al.
BRAIN (2010)
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Gavin Giovannoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Real-Life Impact of Early Interferonβ Therapy in Relapsing Multiple Sclerosis
M. Trojano et al.
ANNALS OF NEUROLOGY (2009)
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
Ludwig Kappos et al.
LANCET NEUROLOGY (2009)
Impact of multiple sclerosis relapses on progression diminishes with time
H. Tremlett et al.
NEUROLOGY (2009)
Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis
Alasdair J. Coles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Natural history of multiple sclerosis with childhood onset
Christel Renoux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Is late-onset multiple sclerosis associated with a worse outcome?
Helen Tremlett et al.
NEUROLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The natural history of multiple sclerosis: a geographically based study - 9: Observations on the progressive phase of the disease
M Kremenchutzky et al.
BRAIN (2006)
Age at disability milestones in multiple sclerosis
C Confavreux et al.
BRAIN (2006)
Natural history of multiple sclerosis: a unifying concept
C Confavreux et al.
BRAIN (2006)
Disability progression in multiple sclerosis is slower than previously reported
H Tremlett et al.
NEUROLOGY (2006)
Concerns about the future among older adults with multiple sclerosis
M Finlayson
AMERICAN JOURNAL OF OCCUPATIONAL THERAPY (2004)
Late-onset multiple sclerosis
ML Polliack et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2001)
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.
LD Jacobs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
